CDKN2A Mutation Analysis, Protein Expression, and Deletion Mapping of Chromosome 9p in Conventional Clear-Cell Renal Carcinomas
Open Access
- 1 February 2001
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 158 (2) , 593-601
- https://doi.org/10.1016/s0002-9440(10)64001-1
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Evaluation of the Clonal Relationship between Primary and Metastatic Renal Cell Carcinoma by Comparative Genomic HybridizationThe American Journal of Pathology, 1999
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- MOLECULAR ANALYSIS OF P16 Ink4 /CDKN2 AND P15 Ink4B /MTS2 GENES IN PRIMARY HUMAN TESTICULAR GERM CELL TUMORSJournal of Urology, 1998
- Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindredsOncogene, 1997
- Contribution of Chromosome 9p21-22 Deletion to the Progression of Human Renal Cell CarcinomaJapanese Journal of Cancer Research, 1995
- Mutational Analysis of CDKN2 (CDK4I/MTS1) Gene in Tissues and Cell Lines of Human Prostate CancerJapanese Journal of Cancer Research, 1995
- Mutations associated with familial melanoma impair p16INK4 functionNature Genetics, 1995
- Response : Rates of p16 ( MTS1 ) Mutations in Primary Tumors with 9p LossScience, 1994
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993